Medtronic Perfusion Tubing Packs, Models TL7M64R3, TL7P17R1 & HY2W85R9, Sterilized using Ethyle...
FDA Device Recall #Z-0268-2016 — Class II — October 28, 2015
Recall Summary
| Recall Number | Z-0268-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 28, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Medtronic Perfusion Systems |
| Location | Brooklyn Park, MN |
| Product Type | Devices |
| Quantity | 496 |
Product Description
Medtronic Perfusion Tubing Packs, Models TL7M64R3, TL7P17R1 & HY2W85R9, Sterilized using Ethylene Oxide. The Tubing Pack design and components are specified by the user, they are packaged with consideration of setup efficiency and respect for the environment, and they are intended for use in the extracorporeal circuit during cardiopulmonary bypass procedures. Medtronic Tubing Packs can contain components with Carmeda BioActive Surface, Trillium BioSurface, Balance BioSurface or no coating. Sterile barrier for these packs is provided either by a Tyvek lid seal on the tray or by a header bag.
Reason for Recall
This recall is being initiated due to a potential breach of the Tubing Pack Header Bags manufactured in these select lots. The seal in question is between the Tyvek and the Poly side of the header bag.
Distribution Pattern
Nationwide Distribution including US: AL, IL, IN, and WI.
Lot / Code Information
Model Lot Numbers Lot Number HY2W85R9 209704344,209704345,209704346, 209704347,210010558 TL7M64R3 209789393 TL7P17R1 209789333
Other Recalls from Medtronic Perfusion Systems
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1473-2026 | Class II | Octopus Nuvo Tissue Stabilizer, disposable tiss... | Jan 13, 2026 |
| Z-0539-2026 | Class II | Medtronic HR-ACT (High Range Activated Clotting... | Oct 20, 2025 |
| Z-0509-2026 | Class II | MC3 VitalFlow Console, REF 58100; Blood pump of... | Oct 3, 2025 |
| Z-0487-2026 | Class II | Affinity NT Oxygenator, Oxygenator with Balance... | Sep 12, 2025 |
| Z-2481-2025 | Class I | DLP Left Heart Vent Catheter Malleable body and... | Aug 6, 2025 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.